C. Autore

C. Autore, M. Volpe, F. Palano, 2018, Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology.

Myocardial repolarization dispersion and late gadolinium enhancement in patients with hypertrophic cardiomyopathy.

C. Autore, A. Maruotti, C. D. De Cecco, 2014, Circulation journal : official journal of the Japanese Circulation Society.

Multimodality Imaging in the Diagnostic Work-Up of Endocarditis and Cardiac Implantable Electronic Device (CIED) Infection

C. Autore, P. Erba, A. Laghi, 2020, Journal of clinical medicine.

Distinguishing Hypertension From Hypertrophic Cardiomyopathy as a Cause of Left Ventricular Hypertrophy

C. Autore, M. Musumeci, P. Francia, 2015, Journal of clinical hypertension.

Subcutaneous implantable cardioverter defibrillator in cardiomyopathies and channelopathies

C. Autore, A. Curcio, D. Corrado, 2018, Journal of cardiovascular medicine.

Eligibility for the Subcutaneous Implantable Cardioverter‐Defibrillator in Patients With Hypertrophic Cardiomyopathy

C. Autore, M. Volpe, F. Palano, 2015, Journal of cardiovascular electrophysiology.

An atypical clinical presentation of renovascular hypertension.

C. Autore, M. Volpe, G. Tocci, 2014, International journal of cardiology.

Diagnosis and management of rare cardiomyopathies in adult and paediatric patients.

C. Autore, C. Indolfi, C. Basso, 2022, International journal of cardiology.

C. Autore, C. Basso, P. Elliott, 2019, International journal of cardiology.

Antimitochondrial autoantibodies in myocardial hypertrophy: comparison between hypertrophic cardiomyopathy, hypertensive heart disease, and athlete's heart.

C. Autore, A. Pelliccia, S. Fiorito, 1988, American heart journal.

Prevalence and Clinical Outcome of Athletes With Mitral Valve Prolapse.

C. Autore, D. Corrado, S. Caselli, 2018, Circulation.

Arterial thrombo-embolic events in cardiac amyloidosis: a look beyond atrial fibrillation

C. Autore, M. Emdin, C. Di Mario, 2020, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

A systematic review on focal takotsubo syndrome: a not-so-small matter

C. Autore, M. Volpe, C. Brunelli, 2020, Heart Failure Reviews.

Prognostic relevance of GRACE risk score in Takotsubo syndrome

C. Autore, C. Di Mario, M. Volpe, 2020, European heart journal. Acute cardiovascular care.

Risk of sudden death and outcome in patients with hypertrophic cardiomyopathy with benign presentation and without risk factors.

C. Autore, B. Maron, C. Rapezzi, 2014, The American journal of cardiology.

Pulmonary embolism in pregnancy

C. Autore, M. Volpe, S. Rubattu, 2014, Journal of Thrombosis and Thrombolysis.

Virilizing Leydig-Sertoli Cell Ovarian Tumor Associated with Endometrioid Carcinoma of the Endometrium in a Postmenopausal Patient: Case Report and General Considerations

C. Autore, A. Fabbri, S. Mariani, 2012, Clinical medicine insights. Case reports.

Role of echocardiography in acute chest pain syndrome.

C. Autore, L. Agati, S. Lino, 2000, The American journal of cardiology.

A case of thrombolysis in acute pulmonary embolism with right atrial thrombus: comparing current and past guidelines

C. Autore, M. Volpe, F. Paneni, 2009, Internal and emergency medicine.

QRS duration and QRS fractionation on surface electrocardiogram are markers of right ventricular dysfunction and atrialization in patients with Ebstein anomaly.

Dionne A. Graham, C. Autore, T. Geva, 2013, European heart journal.

uncomplicated myocardial infarction impact on myocardial tissue perfusion and regional function 1 month after Tissue-type plasminogen activator therapy versus primary coronary angioplasty:

C. Autore, F. Fedele, S. Feinstein, 2011 .

Tissue-type plasminogen activator therapy versus primary coronary angioplasty: impact on myocardial tissue perfusion and regional function 1 month after uncomplicated myocardial infarction.

C. Autore, F. Fedele, S. Feinstein, 1998, Journal of the American College of Cardiology.

Erythropoietin in heart and vessels: focus on transcription and signalling pathways

C. Autore, F. Andreotti, L. Agati, 2008, Journal of Thrombosis and Thrombolysis.

IGF-1 and atherothrombosis: relevance to pathophysiology and therapy.

C. Autore, M. Volpe, V. Mastromarino, 2011, Clinical science.

Noninvasive assessment of myocardial perfusion: preliminary results in patients with acute myocardial infarction.

C. Autore, F. Fedele, A. Dagianti, 2000, The American journal of cardiology.

Impact of a NDUFC2 Variant on the Occurrence of Acute Coronary Syndromes

C. Autore, M. Volpe, S. Rubattu, 2022, Frontiers in Cardiovascular Medicine.

Left ventricular myocardial function in myotonic dystrophy.

C. Autore, L. Badano, G. Antonini, 1993, The American journal of cardiology.

Pulmonary hypertension and clinical correlates in hypertrophic cardiomyopathy.

C. Autore, A. Maruotti, M. Volpe, 2017, International journal of cardiology.

Clinical application of CMR in cardiomyopathies: evolving concepts and techniques

G. Pontone, C. Autore, P. Filardi, 2022, Heart Failure Reviews.

Juvenile sudden death in a family with polymorphic ventricular arrhythmias caused by a novel RyR2 gene mutation: evidence of specific morphological substrates.

G. Danieli, C. Autore, G. Thiene, 2005, Human pathology.

Management of nonischemic-dilated cardiomyopathies in clinical practice: a position paper of the working group on myocardial and pericardial diseases of Italian Society of Cardiology.

C. Autore, C. Basso, G. Limongelli, 2020, Journal of cardiovascular medicine.

Familial idiopathic dilated cardiomyopathy.

C. Autore, D. Cannata, A. Picelli, 1988, American heart journal.

Books Received at the Editorial Office / Announcements

C. Autore, I. Wiklund, A. Filla, 1983 .

Adherence to antiplatelet therapy after percutaneous coronary intervention: a population study in a region of Italy

C. Autore, M. Davoli, C. Perucci, 2015, Journal of cardiovascular medicine.

Accuracy of the "International Criteria" for ECG screening in athletes in comparison with previous published criteria: rationale and design of a diagnostic meta-analysis.

C. Autore, M. Bernardi, G. Biondi‐Zoccai, 2020, Minerva cardioangiologica.

Risk associated with pregnancy in hypertrophic cardiomyopathy.

C. Autore, P. Bruzzi, P. Spirito, 2002, Journal of the American College of Cardiology.

Insights from Cardiopulmonary Exercise Testing in Pediatric Patients with Hypertrophic Cardiomyopathy

C. Autore, A. Maruotti, G. Limongelli, 2021, Biomolecules.

Growth factors in preeclampsia: a vascular disease model. A failed vasodilation and angiogenic challenge from pregnancy onwards?

C. Autore, M. Volpe, M. Musumeci, 2013, Cytokine & growth factor reviews.

Low Sensitivity of Bone Scintigraphy in Detecting Phe64Leu Mutation-Related Transthyretin Cardiac Amyloidosis.

C. Autore, C. Rapezzi, M. Grandis, 2019, JACC. Cardiovascular imaging.

Tortuosity, Recurrent Segments, and Bridging of the Epicardial Coronary Arteries in Patients With the Takotsubo Syndrome.

C. Autore, M. Volpe, G. Marazzi, 2017, The American journal of cardiology.

Update on phase II studies of erythropoietin in acute myocardial infarction. Rationale and design of Exogenous erythroPoietin in Acute Myocardial Infarction: New Outlook aNd Dose Association Study (EPAMINONDAS)

C. Autore, F. Crea, M. Volpe, 2009, Journal of Thrombosis and Thrombolysis.

Exercise oxygen pulse kinetics in patients with hypertrophic cardiomyopathy

C. Autore, G. Sinagra, M. Mapelli, 2022, Heart.

Significance of sarcomere gene mutations analysis in the end-stage phase of hypertrophic cardiomyopathy.

C. Autore, B. Maron, C. Rapezzi, 2014, The American journal of cardiology.

Reevaluation of the South Asian MYBPC3Δ25bp Intronic Deletion in Hypertrophic Cardiomyopathy

Lisa M Anderson, M. Farrall, C. Autore, 2020, Circulation. Genomic and precision medicine.

Clinical application of CMR in cardiomyopathies: evolving concepts and techniques

G. Pontone, C. Autore, P. Filardi, 2022, Heart Failure Reviews.

Current patterns of beta‐blocker prescription in cardiac amyloidosis: an Italian nationwide survey

C. Autore, I. Porto, C. Rapezzi, 2021, ESC heart failure.

Neither Athletic Training nor Detraining Affects LV Hypertrophy in Adult, Low-Risk Patients With HCM.

C. Autore, S. Caselli, A. Pelliccia, 2021, JACC Cardiovascular Imaging.

DOES FOCAL LATE GADOLINIUM ENHANCEMENT AT THE RIGHT VENTRICULAR INSERTION POINTS MATTER IN RISK STRATIFICATION FOR SUDDEN DEATH IN HYPERTROPHIC CARDIOMYOPATHY

E. Cook, W. Manning, C. Autore, 2013 .

Unexpectedly Low Mutation Rates in Beta-Myosin Heavy Chain and Cardiac Myosin Binding Protein Genes in Italian Patients With Hypertrophic Cardiomyopathy

M. Latronico, G. Condorelli, M. Bang, 2011, Journal of cellular physiology.

uence of Residual Perfusion Withion the Infarct Zone o the Natural HistoryLeft Ventricular Dysfunction After Acute MyocardialInfarction My rdl'al Contrast Echocardiographic Study

C. Autore, F. Fedele, M. Penco, 1994 .

Novel α-galactosidase A mutation in patients with severe cardiac manifestations of Fabry disease.

C. Autore, M. Volpe, V. Mastromarino, 2014, Gene.

Patients with hypertrophic cardiomyopathy are getting older.

C. Autore, P. Ferrazzi, 2022, International journal of cardiology.

Simultaneous Takotsubo syndrome in two sisters.

C. Autore, M. Volpe, V. Mastromarino, 2013, International journal of cardiology.

Risk Stratification in Hypertrophic Cardiomyopathy. Insights from Genetic Analysis and Cardiopulmonary Exercise Testing

C. Autore, A. Maruotti, M. Volpe, 2020, Journal of clinical medicine.

Myocardial infarction with non-obstructive coronary arteries in hypertrophic cardiomyopathy vs Fabry disease.

C. Autore, F. Crea, L. Calò, 2022, International journal of cardiology.

Clinical characteristics of patients with takotsubo syndrome recurrence: An observational study with long-term follow-up.

C. Autore, M. Volpe, L. Limite, 2020, International journal of cardiology.

Abstract 4377: Safety and Feasibility of Erythropoietin Administration in Patients with Acute ST-Elevation Myocardial Infarction

C. Autore, A. Rebuzzi, F. Crea, 2008 .

Recombinant human insulin-like growth factor-1: a new cardiovascular disease treatment option?

C. Autore, M. Volpe, M. Musumeci, 2008, Cardiovascular & hematological agents in medicinal chemistry.

Mitochondrial tRNA mutations manifest not only as hypertrophic cardiomyopathy but also as noncompaction--reply.

C. Autore, G. d’Amati, C. Giordano, 2014, Human pathology.

Sudden cardiac death in younger adults: autopsy diagnosis as a tool for preventive medicine.

C. Autore, G. d’Amati, C. D. di Gioia, 2006, Human pathology.

Safety and efficacy of anti‐tachycardia pacing in patients with hypertrophic cardiomyopathy implanted with an ICD

C. Autore, M. Volpe, F. Palano, 2019, Pacing and clinical electrophysiology : PACE.

Mutations in the GLA Gene and LysoGb3: Is It Really Anderson-Fabry Disease?

F. Pieruzzi, C. Autore, C. Zoccali, 2018, International journal of molecular sciences.

Clinical Course of Pregnancy and Long-Term Follow-Up After Delivery in Hypertrophic Cardiomyopathy.

C. Autore, L. Boni, M. Volpe, 2021, Journal of the American College of Cardiology.

Approach to the Initial and Follow-Up Visits

C. Autore, P. Spirito, 2018, Hypertrophic Cardiomyopathy.

Epidural anesthesia for cesarean section in patients with hypertrophic cardiomyopathy: a report of three cases.

C. Autore, F. Fedele, C. Commisso, 1999, Anesthesiology.

Heart Failure Progression in Hypertrophic Cardiomyopathy

C. Autore, A. Maruotti, M. Uguccioni, 2016 .

Stress echocardiography in hypertrophic cardiomyopathy

C. Autore, P. Trambaiolo, F. Fedele, 1996 .

Long-term outcome of nonobstructive versus obstructive hypertrophic cardiomyopathy: A systematic review and meta-analysis.

C. Autore, D. Corrado, C. Basso, 2017, International journal of cardiology.

Incidence and risk factors for pacemaker implantation in light‐chain and transthyretin cardiac amyloidosis

C. Autore, G. Barbati, C. Rapezzi, 2022, European journal of heart failure.

Unmasking the prevalence of amyloid cardiomyopathy in the real world: results from Phase 2 of the AC‐TIVE study, an Italian nationwide survey

G. Parati, C. Autore, M. Metra, 2022, European journal of heart failure.

Clinical translation of genetic testing in TTR Amyloidosis: genotype-phenotype correlations, management of asymptomatic carriers and familial screening

C. Autore, B. Musumeci, M. Sclafani, 2022, Vessel Plus.

A national survey on prevalence of possible echocardiographic red flags of amyloid cardiomyopathy in consecutive patients undergoing routine echocardiography: study design and patients characterization-the first insight from the AC-TIVE Study.

G. Parati, C. Autore, M. Emdin, 2021, European journal of preventive cardiology.

Features and follow-up of patients affected by noninflammatory myocarditis after coronavirus disease 2019 vaccination

C. Autore, M. Volpe, M. Di Girolamo, 2022, Journal of cardiovascular medicine.

The natural course of cardiac conduction disturbances in myotonic dystrophy.

C. Autore, G. Magni, G. Antonini, 1991, Cardiology.

Ambulatory Electrocardiographic Monitoring in Myotonic Dystrophy (Steinert’s Disease)

C. Autore, S. Fiorito, E. Pennisi, 1987 .

Predicting the Unpredictable: How to Score the Risk of Stroke in Cardiac Amyloidosis?

C. Autore, L. Limite, M. Musumeci, 2019, Journal of the American College of Cardiology.

HLA-DR3 antigen linkage in patients with hypertrophic obstructive cardiomyopathy.

C. Autore, S. Fiorito, M. Purpura, 1986, American heart journal.

Isoleucyl-tRNA synthetase levels modulate the penetrance of a homoplasmic m.4277T>C mitochondrial tRNA(Ile) mutation causing hypertrophic cardiomyopathy.

Robert W. Taylor, A. F. Campese, L. Frontali, 2012, Human molecular genetics.

Clinical outcomes in adult athletes with hypertrophic cardiomyopathy: a 7-year follow-up study

C. Autore, S. Caselli, A. Pelliccia, 2020, British Journal of Sports Medicine.

Prognostic Implications of Defibrillation Threshold Testing in Patients With Hypertrophic Cardiomyopathy

C. Autore, M. Volpe, F. Palano, 2017, Journal of cardiovascular electrophysiology.

Clinical Impact of Nonsustained Ventricular Tachycardia Recorded by the Implantable Cardioverter‐Defibrillator in Patients with Hypertrophic Cardiomyopathy

C. Autore, M. Volpe, B. Musumeci, 2014, Journal of cardiovascular electrophysiology.

Transcatheter aortic valve replacement for aortic regurgitation after septal myectomy in patients with obstructive hypertrophic cardiomyopathy.

C. Autore, F. Castriota, L. Limite, 2020, Cardiovascular revascularization medicine : including molecular interventions.

Post-infarction ventricular septal rupture with a contained right ventricular pseudoaneurysm formation

C. Autore, G. Melina, A. Laghi, 2021, BJR case reports.

Multiplane transesophageal echocardiography and stroke.

C. Autore, D. Cartoni, M. Piccininno, 1998, The American journal of cardiology.

Real‐world versus trial patients with transthyretin amyloid cardiomyopathy

C. Autore, C. Rapezzi, S. Perlini, 2019, European journal of heart failure.

Cardiomyopathy and Pregnancy Risk Associated With Pregnancy in Hypertrophic Cardiomyopathy

C. Autore, P. Bruzzi, P. Spirito, 2002 .

Prognostic implications of nonsustained ventricular tachycardia morphology in high‐risk patients with hypertrophic cardiomyopathy

C. Autore, M. Volpe, F. Palano, 2020, Journal of cardiovascular electrophysiology.

CLINICAL SIGNIFICANCE OF LATE GADOLINIUM ENHANCEMENT AT RIGHT VENTRICULAR ATTACHMENT TO VENTRICULAR SEPTUM IN HYPERTROPHIC CARDIOMYOPATHY

W. Manning, C. Autore, B. Maron, 2014 .

The natural history of hypertrophic cardiomyopathy

C. Autore, M. Musumeci, 2020, European heart journal supplements : journal of the European Society of Cardiology.

Relation of delayed Intrinsicoid deflection of the QRS complex to sudden cardiac death in patients with hypertrophic cardiomyopathy.

C. Autore, M. Volpe, M. Musumeci, 2022, International journal of cardiology.

Reply: To PMID 24630786.

C. Autore, B. Maron, P. Spirito, 2014, The American journal of cardiology.

Congenital accessory mitral valve tissue anomaly in a patient with genetically confirmed hypertrophic cardiomyopathy.

C. Autore, B. Musumeci, P. Spirito, 2011, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[ANMCO/SIC Consensus document on the management of myocarditis].

C. Autore, A. di Lenarda, P. Filardi, 2020, Giornale italiano di cardiologia.

Takotsubo syndrome: hyperthyroidism, pheochromocytoma, or both? A case report

C. Autore, M. Musumeci, G. Marino, 2021, European heart journal. Case reports.

Apical hypertrophic cardiomyopathy or left ventricular non-compaction? A difficult differential diagnosis.

C. Autore, P. Spirito, 2007, European heart journal.

Hypertrophic cardiomyopathy in a patient with Down's syndrome.

C. Autore, B. Marino, G. Assenza, 2007, Journal of Cardiovascular Medicine.

Assessment and significance of left ventricular mass by cardiovascular magnetic resonance in hypertrophic cardiomyopathy.

Luigi Rega, Giovanni Quarta, Giancarlo Casolo, 2008, Journal of the American College of Cardiology.

A Next-Generation Sequencing Approach to Identify Gene Mutations in Early- and Late-Onset Hypertrophic Cardiomyopathy Patients of an Italian Cohort

C. Autore, L. Chessa, M. Volpe, 2016, International journal of molecular sciences.

Exploring the influence of takotsubo syndrome on oncologic patients’ mortality

C. Autore, P. Spallarossa, L. Cacciotti, 2022, Frontiers in Cardiovascular Medicine.

High risk for sudden death identified by electrocardiographic loop recording in a patient with hypertrophic cardiomyopathy without major risk factors.

C. Autore, M. Musumeci, P. Spirito, 2011, The American journal of cardiology.

Low QRS Voltages in Cardiac Amyloidosis

C. Autore, S. Iliceto, M. De Gaspari, 2022, JACC. CardioOncology.

Maternally inherited cardiomyopathy: clinical and molecular characterization of a large kindred harboring the A4300G point mutation in mitochondrial deoxyribonucleic acid.

C. Autore, F. Santorelli, C. Casali, 1999, Journal of the American College of Cardiology.

Drugs and Cardiotoxicity in HIV and AIDS

C. Autore, M. Fantoni, C. Borgo, 2001, Annals of the New York Academy of Sciences.

Targeted next-generation sequencing helps to decipher the genetic and phenotypic heterogeneity of hypertrophic cardiomyopathy

C. Autore, C. Rapezzi, C. Forleo, 2016, International journal of molecular medicine.

Prognostic Value of Quantitative Contrast-Enhanced Cardiovascular Magnetic Resonance for the Evaluation of Sudden Death Risk in Patients With Hypertrophic Cardiomyopathy

E. Cook, M. Pencina, W. Manning, 2014, Circulation.

Evaluation and management of metabolic and coagulative disorders in HIV-infected patients receiving highly active antiretroviral therapy.

C. Autore, M. Fantoni, C. Del Borgo, 2003, AIDS.

Common genetic variants and modifiable risk factors underpin hypertrophic cardiomyopathy susceptibility and expressivity

M. Farrall, C. Autore, S. Petersen, 2021, Nature Genetics.

Hyperthrophic cardiomyopathy and the PTPN11 gene

C. Autore, B. Dallapiccola, A. Pizzuti, 2005, American journal of medical genetics. Part A.

TNNI3 and KCNQ1 co-inherited variants in a family with hypertrophic cardiomyopathy and long QT phenotypes: A case report

C. Autore, M. Torrisi, S. Rubattu, 2021, Molecular genetics and metabolism reports.

Arterial thrombotic events and acute coronary syndromes with cancer drugs: are growth factors the missed link?: what both cardiologist and oncologist should know about novel angiogenesis inhibitors.

C. Autore, P. Marchetti, M. Volpe, 2013, International journal of cardiology.

Approach to hypertrophic cardiomyopathy

C. Autore, P. Spirito, 2004, Current treatment options in cardiovascular medicine.

Pathogenesis of Chronic Cardiorenal Syndrome: Is There a Role for Oxidative Stress?

C. Autore, M. Volpe, S. Rubattu, 2013, International journal of molecular sciences.

Prevalence and prognostic role of nonsustained ventricular tachycardia in cardiac amyloidosis

C. Autore, F. Perfetto, M. Zampieri, 2022, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

Left Ventricular Remodeling in Hypertrophic Cardiomyopathy: An Overview of Current Knowledge

C. Autore, F. Palano, B. Musumeci, 2021, Journal of clinical medicine.

Approach to the Initial and Follow-Up Visits

C. Autore, P. Spirito, 2015 .

Determinants of peak oxygen uptake in patients with hypertrophic cardiomyopathy: a single-center study

C. Autore, A. Maruotti, M. Volpe, 2014, Internal and Emergency Medicine.

Management of hypertrophic cardiomyopathy

C. Autore, Paolo Spirito, P. Spirito, 2006, BMJ : British Medical Journal.

The prognostic importance of left ventricular outflow obstruction in hypertrophic cardiomyopathy varies in relation to the severity of symptoms.

C. Autore, P. Bruzzi, P. Spirito, 2005, Journal of the American College of Cardiology.

Natriuretic Peptides: It Is Time for Guided Therapeutic Strategies Based on Their Molecular Mechanisms

C. Autore, S. Rubattu, G. Gallo, 2023, International journal of molecular sciences.

Cardiomyopathies due to homoplasmic mitochondrial tRNA mutations: morphologic and molecular features.

Robert W. Taylor, C. Autore, V. Petrozza, 2013, Human pathology.

Infective endocarditis in hypertrophic cardiomyopathy: prevalence, incidence, and indications for antibiotic prophylaxis.

C. Autore, P. Bruzzi, C. Rapezzi, 1999, Circulation.

Lack of Influence of the Androgen Receptor Gene CAG-Repeat Polymorphism on Clinical and Electrocardiographic Manifestations of the Brugada Syndrome in Man

C. Autore, M. Volpe, B. Musumeci, 2012, Clinical Medicine Insights. Cardiology.

Long-Term Outcome of Acute Coronary Syndromes in Young Patients

C. Autore, M. Volpe, M. Casenghi, 2017, High Blood Pressure & Cardiovascular Prevention.

Influence of residual perfusion within the infarct zone on the natural history of left ventricular dysfunction after acute myocardial infarction: a myocardial contrast echocardiographic study.

C. Autore, F. Fedele, F. Bilotta, 1994, Journal of the American College of Cardiology.

Risk stratification and prevention of sudden death in hypertrophic cardiomyopathy

C. Autore, G. Quarta, P. Spirito, 2007, Current treatment options in cardiovascular medicine.

Admission heart rate and in-hospital course of patients with Takotsubo syndrome.

C. Autore, M. Volpe, G. Marazzi, 2018, International journal of cardiology.

Electrocardiographic changes in focal takotsubo syndrome: a case report.

C. Autore, M. Volpe, L. Limite, 2019, Journal of cardiovascular medicine.

Extreme Left Vetricular Hypertrophy: An Indicator of Increased Risk of Sudden Death in Hypertrophic Cardiomyopathy

C. Autore, P. Spirito, P. Bernabò, 2004 .

Effectiveness of the 2014 European Society of Cardiology guideline on sudden cardiac death in hypertrophic cardiomyopathy: a systematic review and meta-analysis

C. Autore, R. Omar, P. Elliott, 2018, Heart.

Cardiopulmonary exercise test and sudden cardiac death risk in hypertrophic cardiomyopathy

C. Autore, A. Maruotti, G. Limongelli, 2016, Heart.

Sudden Death Risk in Patients With Hypertrophic Cardiomyopathy Prognostic Value of Quantitative Contrast-Enhanced Cardiovascular Magnetic Resonance

E. Cook, M. Pencina, W. Manning, 2014 .

Prevention of sudden cardiac death with implantable cardioverter-defibrillators in children and adolescents with hypertrophic cardiomyopathy.

M. Link, E. Ashley, G. Boriani, 2013, Journal of the American College of Cardiology.

Prognosis of Asymptomatic Patients With Hypertrophic Cardiomyopathy and Nonsustained Ventricular Tachycardia

C. Autore, P. Bruzzi, A. Branzi, 1994, Circulation.

Long-Term Left Ventricular Remodeling of Patients With Hypertrophic Cardiomyopathy.

C. Autore, M. Volpe, D. Magrí, 2018, The American journal of cardiology.

Syncope and Risk of Sudden Death in Hypertrophic Cardiomyopathy

C. Autore, B. Maron, P. Bruzzi, 2009, Circulation.

Patterns of left ventricular longitudinal strain and strain rate in Olympic athletes.

C. Autore, S. Caselli, N. Pandian, 2015, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

Red Blood Cell Distribution Width in Acute Coronary Syndromes

C. Autore, M. Volpe, A. Tonino, 2013 .

Clinical Course and Quality of Life in High-Risk Patients With Hypertrophic Cardiomyopathy and Implantable Cardioverter-Defibrillators

G. Boriani, C. Autore, B. Maron, 2018, Circulation. Arrhythmia and electrophysiology.

Significance of Late Gadolinium Enhancement at Right Ventricular Attachment to Ventricular Septum in Patients With Hypertrophic Cardiomyopathy.

W. Manning, C. Autore, W. Roberts, 2015, The American journal of cardiology.

Clinical application of CMR in cardiomyopathies: evolving concepts and techniques

G. Pontone, C. Autore, P. Filardi, 2022, Heart Failure Reviews.

Long QTc in hypertrophic cardiomyopathy: A consequence of structural myocardial damage or a distinct genetic disease?

C. Autore, A. Pizzuti, M. Volpe, 2023, Frontiers in Cardiovascular Medicine.

Outcomes of early invasive treatment strategy in elderly patients with non-ST elevation acute coronary syndromes

C. Autore, M. Volpe, D. Fusco, 2016, Journal of cardiovascular medicine.

Limitations of the electrocardiographic diagnosis of left ventricular hypertrophy: the influence of left anterior hemiblock and right bundle branch block.

C. Autore, G. Magni, P. Fragola, 1992, International journal of cardiology.

Electrocardiographic diagnosis of left ventricular hypertrophy in the presence of left bundle branch block: a wasted effort.

C. Autore, P. Fragola, D. Cannata, 1990, International journal of cardiology.

Substrates of Scar-Related Ventricular Arrhythmia in Patients With Hypertrophic Cardiomyopathy: A Cardiac Magnetic Resonance Study.

C. Autore, D. Soto-Iglesias, A. Berruezo, 2023, JACC Cardiovascular Imaging.

Autoantibodies in myotonic dystrophy.

C. Autore, S. Fiorito, G. Antonini, 1989, Allergie et immunologie.

Long-term management of Takotsubo syndrome: a not-so-benign condition.

C. Autore, M. Volpe, L. Limite, 2021, Reviews in cardiovascular medicine.

Three-dimensional echocardiographic characterization of patients with left ventricular noncompaction.

C. Autore, S. Caselli, A. Pelliccia, 2012, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

The Microvolt T-Wave Alternans Test

C. Autore, G. Quarta, F. Paneni, 2007 .

Old and new therapeutic solutions in the treatment of hypertrophic cardiomyopathy

C. Autore, B. Musumeci, G. Tini, 2023, European heart journal supplements : journal of the European Society of Cardiology.

Non-alcoholic fatty liver disease and heart valve disease: a neglected link.

C. Autore, E. Cavarretta, M. Peruzzi, 2020, Minerva cardioangiologica.

Risk stratification in transthyretin-related cardiac amyloidosis

C. Autore, B. Musumeci, M. Sclafani, 2023, Frontiers in Cardiovascular Medicine.

Yield of bone scintigraphy screening for transthyretin‐related cardiac amyloidosis in different conditions: Methodological issues and clinical implications

C. Autore, P. Vianello, S. Benenati, 2021, European journal of clinical investigation.

A Novel Nonsense Pathogenic TTN Variant Identified in a Patient with Severe Dilated Cardiomyopathy

C. Autore, A. Pizzuti, M. Fabiani, 2023, Current issues in molecular biology.

Restrictive cardiomyopathy and pseudoxanthoma elasticum skin lesions.

C. Autore, M. Volpe, F. Socciarelli, 2016, Journal of Cardiovascular Medicine.

Implantable cardioverter-defibrillators for hypertrophic cardiomyopathy: The Times They Are a-Changin'.

P. Lambiase, C. Autore, I. Olivotto, 2021, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

From the phenotype to precision medicine: an update on the cardiomyopathies diagnostic workflow

C. Autore, G. Limongelli, L. Crotti, 2023, Journal of cardiovascular medicine.

Metabolic disorders and cardiovascular risk in HIV-infected patients treated with antiretroviral agents.

C. Autore, M. Fantoni, C. Del Borgo, 2002, Italian heart journal : official journal of the Italian Federation of Cardiology.

Diagnostic pathways to wild‐type transthyretin amyloid cardiomyopathy: a multicentre network study

C. Mazzoni, C. Autore, M. Emdin, 2023, European journal of heart failure.

Electrocardiographic heterogeneity of patients with variant transthyretin amyloid cardiomyopathy: Genotype-phenotype correlations.

C. Autore, R. Licordari, G. Sinagra, 2023, International journal of cardiology.

The role of genetic testing in suspected fulminant myocarditis: A case report

C. Autore, A. Pizzuti, M. Fabiani, 2023, Molecular genetics and metabolism reports.

Clinical course of hypertrophic cardiomyopathy patients implanted with a transvenous or subcutaneous defibrillator

C. Autore, M. Biffi, M. Ziacchi, 2023, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Apical hypertrophic cardiomyopathy or left ventricular non-compaction? A difficult differential diagnosis.

C. Autore, P. Spirito, 2007, European heart journal.

The prognostic importance of left ventricular outflow obstruction in hypertrophic cardiomyopathy varies in relation to the severity of symptoms.

C. Autore, P. Bruzzi, P. Spirito, 2005, Journal of the American College of Cardiology.

Spatial QT Dispersion Predicts Nonsustained Ventricular Tachycardia and Correlates with Confined Systodiastolic Dysfunction in Hypertrophic Cardiomyopathy

C. Autore, A. Maruotti, C. D. De Cecco, 2015, Cardiology.

Risk stratification and prevention of sudden death in hypertrophic cardiomyopathy

C. Autore, G. Quarta, P. Spirito, 2007, Current Treatment Options in Cardiovascular Medicine.

Arterial thrombotic events and acute coronary syndromes with cancer drugs: are growth factors the missed link?: what both cardiologist and oncologist should know about novel angiogenesis inhibitors.

C. Autore, P. Marchetti, M. Volpe, 2013, International journal of cardiology.

PROGNOSTIC UTILITY OF CONTRAST-ENHANCED CARDIOVASCULAR MAGNETIC RESONANCE IN HYPERTROPHIC CARDIOMYOPATHY: AN INTERNATIONAL MULTICENTER STUDY

E. Cook, W. Manning, C. Autore, 2012 .

The Diagnostic Value of the 12-Lead ECG in Arrhythmogenic Left Ventricular Cardiomyopathy: Novel ECG Signs.

C. Autore, F. Gaita, L. Calò, 2023, JACC. Clinical electrophysiology.

ECG/echo indexes in the diagnostic approach to amyloid cardiomyopathy: A head-to-head comparison from the AC-TIVE study.

C. Autore, I. Olivotto, R. Pavasini, 2023, European journal of internal medicine.

‘QRS duration and QRS fractionation on surface electrocardiogram are markers of right ventricular dysfunction and atrialization in patients with Ebstein anomaly’ [Eur Heart J 2012;34:191–200, doi:10.1093/eurheartj/ehs362]

Dionne A. Graham, C. Autore, T. Geva, 2013 .

Prevalence and Clinical Outcome of Athletes With Mitral Valve Prolapse.

C. Autore, D. Corrado, S. Caselli, 2018, Circulation.

Transcatheter Ablation of Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy

C. Autore, G. Barbati, F. Gaita, 2024, JACC. Advances.

Impact of the Noninvasive Diagnostic Algorithm on Clinical Presentation and Prognosis in Cardiac Amyloidosis

C. Mazzoni, C. Autore, Margherita Zanoletti, 2024, JACC. Advances.

Role of advanced CMR features in identifying a positive genotype of hypertrophic cardiomyopathy.

Sarah Ghulam Ali, D. Andreini, C. Autore, 2024, International journal of cardiology.

Real‐world candidacy to mavacamten in a contemporary hypertrophic obstructive cardiomyopathy population

C. Autore, G. Sinagra, F. Re, 2023, European journal of heart failure.

Severe left ventricular wall thinning and extensive fibrosis without evolution to end stage disease in a patient with hypertrophic cardiomyopathy.

C. Autore, M. Lombardi, G. Quarta, 2009, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.